Westlake Precision Nutrition Study
1 other identifier
interventional
176
1 country
1
Brief Summary
This is a dietary intervention study, which aims to explore different diet challenges for glucose metabolism, including carbohydrates and intermittent fasting (IF) dietary pattern. Considering the glucose responses to the same food are largely heterogeneous among people, this study integrates the concepts of precision nutrition and N-of-1 design. The study also aims to explore differences in brain structure and function between participants with different Body Mass Index (BMI) from the perspective of gut-brain axis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable healthy
Started Oct 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 24, 2021
CompletedFirst Posted
Study publicly available on registry
September 23, 2021
CompletedStudy Start
First participant enrolled
October 8, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 27, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 12, 2022
CompletedSeptember 5, 2023
August 1, 2021
3 months
August 24, 2021
August 31, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Blood glucose profiling
Real-time blood glucose fluctuations will be recorded by CGM.
14 days
Change of glucose tolerance before and after intermittent fasting
Oral glucose tolerance test will also be conducted.
Day 8 and Day 13
Other Outcomes (14)
Changes of fecal and urine metabolomics profiling
Day 1, Day 8 , Day 11 and Day 14
Changes of serum metabolomics profiling
Day 1, and Day 14
Changes of interleukin-1β (IL-1β), IL-6, IL-12
Day 1, and Day 14
- +11 more other outcomes
Study Arms (3)
refined carbohydrate breakfast (Breakfast A)
EXPERIMENTALwhite bread (50g) + milk powder (25g)
whole grain breakfast (Breakfast B)
EXPERIMENTALplain oats (35g) + milk powder (25g)
intermittent fasting (IF)
EXPERIMENTALInterventions
After wearing CGM on Day 1, participants will be provided with breakfast A once daily on Day 2, Day 5 and Day 6. Breakfast A contains white bread (50g) and milk powder (25g). Since lunch and dinner would serve as wash-out meals, participants will be free to choose food but provide a record of their diets.
After wearing CGM on Day 1, participants will be provided with Breakfast B once daily on Day 3, Day 4 and Day 7. Breakfast B contains plain oats (35g) and milk powder (25g). Since lunch and dinner would serve as wash-out meals, participants will be free to choose food but provide a record of their diets.
The period during Day 8 to Day 13 is intermittent fasting period. Participants will experience the moderate fasting on Day 9 and Day 12, which means their daily energy intake is expected to be controlled within 500-600 kcal limit. In these two days, participants will be provided with all three meals. Percentages of macronutrients of provided meals will follow the Recommended Dietary Health guidelines for Chinese residents. The oral glucose tolerance test (OGTT) will be conducted in the morning on Day 8 and Day 13, to test short-term impact of IF intervention on individuals' glucose tolerance. The breakfasts on Day 10 and Day 11 will be the same as that in fasting days. Other meals will be wash-out meals.
Eligibility Criteria
You may qualify if:
- Participants reside in Hangzhou
- Participants have no traveling plans within 3 months
You may not qualify if:
- Refusing or unable to give informed consent
- Participants with chronic gastrointestinal diseases and take daily relevant medications
- Participants with metabolic diseases including diabetes, hypertension and cardiovascular diseases (CVD)
- Participants with craniocerebral trauma, cancer, liver disease, kidney disease, or other critical illness, or history of operation or medication
- Participants with bulimia nervosa, post-traumatic stress disorder (PTSD), chronic anxiety and depression or other critical neuronal disorder or history of relevant medication
- Being or to be pregnant or lactating.
- Participants with history of alcohol or drug addiction, or smoke above 15 cigarettes per day
- Concurrently participating other clinical trials.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Westlake University
Hangzhou, Zhejiang, 310024, China
Related Publications (1)
Zhang K, Fu Y, Gou W, Miao Z, Tian Y, Liang Y, Liang X, Shuai M, Xiao C, Wang J, Xu F, Jiang Z, Gao C, Ma S, Ordovas JM, Zheng JS. Quantification of personalized glycemic sensitivity to food and its potential for precision nutrition in a series of n-of-1 trials. Am J Clin Nutr. 2025 Aug;122(2):502-512. doi: 10.1016/j.ajcnut.2025.04.015. Epub 2025 Jun 19.
PMID: 40754388DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ju-Sheng Zheng, PhD
Westlake University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 24, 2021
First Posted
September 23, 2021
Study Start
October 8, 2021
Primary Completion
December 27, 2021
Study Completion
July 12, 2022
Last Updated
September 5, 2023
Record last verified: 2021-08